Market Research Logo

Global In-Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook (2017-2021)

Global In-Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook (2017-2021)

Diagnosis is the identification of the nature and cause of a certain phenomenon. It involves two different types of testing method: in vivo and in vitro diagnostics. In-vitro diagnostics (IVDs) tests are defined as tests executed outside a patient’s body which put analytical instruments, devices, reagents, calibrators and systems to use for checking of health status or diagnosing diseases. Purpose for doing the IVD test is to prevent, effectively cure and mitigate any kind of risk and for post-treatment intensive care diseases and infections. IVD products are precisely designed and produced for collecting samples derived from the human body and scrutinizing them outside the human body.

The global IVD market is segmented on the basis of product, technology used and test location. On the basis of product, this market can be divided into three sub segments; reagents, analytical instruments and accessory products. By technologies employed, it can be segmented into various sub segments; immunochemistry, SMBG, POCT, molecular diagnostics, clinical chemistry, microbiology, hematology and others. Further, depending upon test location, the market can be divided into three sub segments; labs, POC and self-test.

Growth of the global IVD market is driven by several factors including rapid occurrence of infectious diseases, increasing diabetic patient base, and surge in incidences of chronic ailments. Further, growing geriatric population, rising GDP per capita and increasing healthcare expenditure per capita will act as a catalyst for market growth. Owing to the suitable demographical changes and rising disposable income coupled with improving basic infrastructure, developing regions such as Asia-Pacific and Latin America are expected to experience robust growth. However, the market growth prospects could be hindered by lack of customer adoption, lack of proper facilities and infrastructure and strict government regulations.

The report “Global In-Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook (2017-2021)” analyzes the development of this market, with focus on the North America, EMEA, Asia-Pacific and Latin America markets. The major trends, growth drivers as well as issues faced by the market are discussed in detail in this report. The four major players: Siemens AG., Roche Holdings AG., Abbott Laboratories and Danaher Corp. are being profiled along with their key financials and strategies for growth.


1. Overview
1.1 In-Vitro Diagnostics (IVD)
Table 1: Types of Diagnostics
1.2 IVD Product by Types
Table 2: Types of IVD Products
1.3 IVD Tests
Table 3: Types of IVD Tests
1.4 IVD Market by Technology
Table 4: IVD Market by Technology
1.5 IVD Uses
1.6 IVD Value Chain Analysis
Table 5: IVD Value Chain Analysis
2. Global IVD Market
2.1 Global IVD Market by Value
Table 6: Global IVD Market by Value (2012-2016)
2.2 Global IVD Market Forecast by Value
Table 7: Global IVD Market Forecast by Value (2017-2021)
2.3 Global IVD Market by Region
Table 8: Global IVD Market by Region (2016)
2.4 Global IVD Market by Indications
Table 9: Global IVD Market by Indications (2016)
2.5 Global IVD Market by Test Location
Table 10: Global IVD Market by Test Location (2016)
2.6 Global IVD Market by Product
Table 11: Global IVD Market by Product (2016)
2.6.1 Global IVD Reagents Market Forecast by Value
Table 12: Global IVD Reagents Market Forecast by Value (2016-2021)
2.6.2 Global IVD Instrument Market Forecast by Value
Table 13: Global IVD Instrument Market Forecast by Value (2016-2021)
2.7 Global IVD Market by Technology
Table 14: Global IVD Market by Technology (2016)
3. Global IVD Market Analysis by Technology
3.1 Global SMBG Market Forecast by Value
Table 15: Global SMBG Market Forecast by Value (2016-2021)
3.2 Global Clinical Chemistry Market Forecast by Value
Table 16: Global Clinical Chemistry Market Forecast by Value (2016-2021)
3.3 Global Immunochemistry Market
3.3.1 Global Immunochemistry Market Forecast by Value
Table 17: Global Immunochemistry Market Forecast by Value (2016-2021)3.3.2 Global Immunochemistry Market by Indications
Table 18: Global Immunochemistry Market by Indications (2016)
3.4 Global Molecular Diagnostics Market
3.4.1 Global Molecular Diagnostics Market Forecast by Value
Table 19: Global Molecular Diagnostics Market Forecast by Value (2016-2021)
3.4.2 Global Molecular Diagnostics Market by Indications
Table 20: Global Molecular Diagnostics Market by Indications (2016)
3.4.3 Global Molecular Diagnostics Market by Regions
Table 21: Global Molecular Diagnostics Market by Regions (2016)
3.5 Global Point Of Care (POC) Market Forecast by Value
Table 22: Global Point Of Care (POC) Market Forecast by Value (2016-2021)
3.6 Global Microbiology Market
3.6.1 Global Microbiology Market Forecast by Value
Table 23: Global Microbiology Market Forecast by Value (2016-2021)
3.6.2 Global Microbiology Market by Indication
Table 24: Global Microbiology Market by Indication (2016)
3.7 Global Hematology Market Forecast by Value
Table 25: Global Hematology Market Forecast by Value (2016-2021)
4. Regional IVD Market
4.1 North America
4.1.1 North America IVD Market Forecast by Value
Table 26: North America IVD Market Forecast by Value (2016-2021)
4.1.2 North America Microbiology Market by Indication
Table 27: North America Microbiology Market by Indication (2016)
4.1.3 The US IVD Market Forecast by Value
Table 28: The US IVD Market Forecast by Value (2016-2021)
4.2 EMEA
4.2.1 EMEA IVD Market Forecast by Value
Table 29: EMEA IVD Market Forecast by Value (2016-2021)
4.2.2 Europe Microbiology Market by Indications
Table 30: Europe Microbiology Market by Indications (2016)
4.3 Asia-Pacific
4.3.1 Asia-Pacific IVD Market Forecast by Value
Table 31: Asia-Pacific IVD Market Forecast by Value (2016-2021)
4.3.2 China IVD Market Forecast by Value
Table 32: China IVD Market Forecast by Value (2016-2021)
4.3.3 Japan IVD Market Forecast by Value
Table 33: Japan IVD Market Forecast by Value (2016-2021)
4.4 Latin America
4.4.1 Latin America IVD Market Forecast by Value
Table 34: Latin America IVD Market Forecast by Value (2016-2021)
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increasing Diabetic Patient Base
Table 35: Global Type 2 Diabetes Patients Volume (2016-2021)
5.1.2 Rapid Occurrence of Infectious Diseases
Table 36: Growing Cases and Prevalence of STDs in the US (2012-2016)
5.1.3 Surge in Incidences of Chronic Ailments
Table 37: Global New Cancer Patients Volume (2012-2016)
5.1.4 Increasing Global Healthcare Expenditure Per Capita
Table 38: Global Healthcare Expenditure Per Capita (2012-2016)
5.1.5 Rising Global GDP per Capita
Table 39: Global GDP Per Capita (2012-2016)
5.1.6 Growing Geriatric Population
Table 40: Global Population above 64 Years (2012-2016)
5.2 Key Trends & Developments
5.2.1 Rise in CFDA IVD Market Approvals
5.2.2 Consolidation of Core Labs
5.2.3 Increasing Penetration of the US LDT Companies in European IVD Market
5.2.4 Mergers & Acquisitions
5.3 Challenges
5.3.1 Lack of Customer Adoption
5.3.2 Urgent Need for Proper Infrastructure
5.3.3 Government Regulation for IVD Tests
6. Competitive Landscape
6.1 Global IVD Market
6.1.1 Revenue and Market Cap. Comparison
Table 41: Revenue and Market Cap. Comparison by Company (2016)
6.1.2 Global IVD Market Share by Company
Table 42: Global IVD Market Share by Company (2016)
6.1.3 Global Immunochemistry Market Share by Company
Table 43: Global Immunochemistry Market Share by Company (2016)
6.1.4 Global Molecular Diagnostics Market Share by Company
Table 44: Global Molecular Diagnostics Market Share by Company (2016)
6.1.5 Global POCT Market Share by Company
Table 45: Global POCT Market Share by Company (2016)
7. Company Profiles
7.1 Siemens AG
7.1.1 Business Overview
Table 46: Siemens AG Revenue by Segment (2016)
7.1.2 Financial Overview
Table 47: Siemens AG Revenue and Net Income (2012-2016*)
7.1.3 Business Strategies
Table 48: Siemens R&D Expenditure (2014-2016*)
7.2 Roche Holding AG
7.2.1 Business Overview
Table 49: Roche Holding AG Sales by Segment (2016)
7.2.2 Financial Overview
Table 50: Roche Holding AG Sales and Net Income (2012-2016)
7.2.3 Business Strategies
Table 51: Roche Holding AG R&D Expenditure (2014-2016)
Table 52: Number of Products In Pipeline by Segments (2016)
7.3 Abbott Laboratories
7.3.1 Business Overview
Table 53: Abbott Laboratories Sales by Segment (2016)
7.3.2 Financial Overview
Table 54: Abbott Laboratories Net Sales and Net Earnings (2012-2016)
7.3.3 Business Strategies
Table 55: Abbott Laboratories R&D Expenditure (2014-2016)
7.4 Danaher Corporation
7.4.1 Business Overview
Table 56: Danaher Corp. Revenue by Segments (2016)
7.4.2 Financial Overview
Table 57: Danaher Corp. Revenue and Net Earnings (2012-2016)
7.4.3 Business Strategies
Table 58: Danaher Corp. R&D Expenditure (2014-2016)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report